Ribera bets on a “software” to better detect breast cancer

The Ribera group, owner of Povisa, has invested in software that, with advanced data analytics and artificial intelligence, establishes biomarkers from magnetic resonance images that configure a virtual biopsy to achieve a more precise diagnosis of breast cancer . The goal is to turn this program into a tool that helps radiologists.